Delivery Order SPE2DE24D0013-SPE2D626F085C
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. on November 4, 2025, with an ultimate completion date of November 12, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing supplies and reagents for detecting COVID-19, influenza, and respiratory syncytial virus. Cepheid, headquartered in Sunnyvale, California, is a leading federal supplier of advanced molecular diagnostic systems and...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- The U.S. Defense Logistics Agency, through the Medical Supply Chain division, awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The delivery order addresses federal requirements for COVID-19, influenza, and respiratory syncytial virus...
- The Defense Logistics Agency awarded a delivery order to Cepheid Inc. for molecular diagnostic solutions under a firm fixed-price contract valued at $15,440, with an ultimate completion date of October 1, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, supports testing capabilities for COVID-19, influenza, and respiratory syncytial virus detection. The contract contains no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid, a for-profit...
- The U.S. Defense Logistics Agency (under the Medical Supply Chain function) awarded a $6,800 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on August 18, 2025, with an ultimate completion date of August 25, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The award reflects Cepheid's specialized expertise in providing rapid molecular diagnostic testing for...
- The U.S. Defense Logistics Agency, operating through the Medical Supply Chain function, awarded a $13,464 firm fixed-price delivery order to Cepheid Inc. on July 15, 2025, with an ultimate completion date of July 29, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, was issued without a set-aside designation and represents procurement of molecular diagnostic solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The work will be performed at Cepheid's facility...
- The Defense Logistics Agency's Medical Supply Chain has awarded a $7,904 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, represents procurement of diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract was awarded on September 8, 2025, with an ultimate completion date of September 15, 2025, and carries no...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,992 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems and reagents, on November 5, 2025, with an ultimate completion date of November 20, 2025. This firm fixed-price delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic supplies related to COVID-19, influenza, and respiratory syncytial virus testing. The contract carries no set-aside designation,...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a $12,086.88 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The delivery order, issued on August 6, 2025, with completion targeted for August 13, 2025, is designated XPCOV2/FLU/RSV-10 and carries no set-aside designation. This award represents a delivery order issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, likely the...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $14,448 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and will be performed at Cepheid's...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F085CDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. on November 10, 2025, with an ultimate completion date of November 18, 2025. This delivery order, issued under contract number 4569971788 for the XPCOV2/FLU/RSV-10 product line, represents a procurement of molecular diagnostic testing supplies and reagents for detecting COVID-19, influenza, and respiratory syncytial virus. The contract carries no set-aside designation and is being performed at Cepheid's headquarters location in Sunnyvale, California. Cepheid, a leading manufacturer of advanced molecular diagnostic systems, has established itself as a primary federal supplier across multiple federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. This delivery order is likely issued under one of Cepheid's existing indefinite delivery vehicles with the Department of Veterans Affairs or Defense Logistics Agency, which serve as the primary contracting mechanisms for the company's diagnostic testing solutions. The relatively modest contract value reflects a single ordering period for molecular diagnostic reagents and test kits designed to support federal clinical laboratory operations and infectious disease testing requirements. Cepheid's extensive portfolio of firm fixed-price contracts across multiple federal healthcare facilities demonstrates the company's competitive positioning in the federal molecular diagnostics procurement market and its critical role in supplying rapid diagnostic testing capabilities for respiratory pathogens throughout the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 11/10/25 |